Single-Use Bioprocessing Market Size
The Single-use Bioprocessing Market reached US$ 9.7 billion in 2025 and is expected to reach US$ 35.75 billion by 2033, growing at a CAGR of 18.64% during the forecast period 2026-2033.
Single-use bioprocessing systems are bioprocessing equipment that is used once and disposed of. Single-use bioprocessing systems are made up of plastic components that can be sterilized and sealed by using gamma irradiation. Single-use bioprocessing systems are used for mixing, filtration, purification, upstream expression, storage, and separation of biopharmaceutical products. The market is dominated by the availability of several single-use bioprocessing systems such as bioreactors & fermenters, mixers, bags, bioprocess containers, and filtration.
Market Summary
| Metrics | Details |
| Market CAGR | 18.64% |
| Segments Covered | By Product, By Application, By End User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To know more insights, get our Sample Brochure
Single-Use Bioprocessing Market Dynamics
The market is driven by the increasing demand for single-use bioprocessing systems with the growing penetration of biopharmaceuticals. Single-use bioprocessing systems have several advantages, such as high energy efficiency, low water usage, less floor space requirement, and very low or no risk of product cross-contamination. Single-use bioprocessing systems are faster to implement.
The problem associated with waste disposal is likely to hamper the growth of the single-use bioprocessing market
Biopharmaceutical firms are increasingly adopting single-use bioprocessing Products due to the numerous benefits associated with them, including cost savings, faster process development time, and lower capital investments. However, there are still serious concerns about the disposal of solid waste materials generated by this alternative technology. Recycling is not an option for such products because separating the components into homogeneous parts requires significant effort. As a result, most single-use systems and their parts are unsuitable for recycling. These factors are hampering the growth of the market in the forecast period.
Industry Analysis
The global single-use bioprocessing market provides in-depth analysis of the market based on various industry factors such as porter’s five forces, regulatory analysis, supply chain analysis and pricing analysis.
Single-Use Bioprocessing Market Segment Analysis
Disposable/ single-use bioreactor segment is expected to hold the largest market share in global single-use bioprocessing market
The single-use bioprocessing market is segmented based on product as media bags and containers, filtration assemblies, disposable/single-use bioreactors, disposable mixers, and others. The disposable/single-use bioreactors segment accounts for a significant market share in 2019. The disposable/single-use bioreactors comprised of the disposable bag instead of a culture vessel. Disposable/single-use bioreactors that are ideal for mammalian cell culture depend on high cell density or microcarrier-based processes. Single-use bioreactors reduce the cleaning and sterilization demands. These bioreactors are effective for enhancing biological and process safety. The market is dominated by the availability of several disposable/single-use bioreactors. For instance, Sartorius’s single-use bioreactors i.e., Ambr15 to BiostatSTR 2,000 L have been developed to ensure easy scale-up and scale-down. It is combined with unprecedented high performance even at a large scale. These bioreactors make the products perfectly suitable to serve all the current and future needs from process development to commercial production phases. Several companies are expanding their manufacturing facilities with the use of disposable/single-use bioreactors. For instance, MilliporeSigma had expanded its single-use cGMP facility with the addition of the Mobius 2,000 L single-use bioreactor, enabling the company to provide upstream development and manufacturing services using its equipment through its Provantage End-to-End Services offering
Further, the single-use bioprocessing market is also classified based on the end-users as biopharmaceutical manufacturers, life science R&D companies, academic research institutes, contract research organizations & manufacturers, and others. The contract research organizations & manufacturers segment accounts for the highest market share. Contract research organizations & manufacturers are focusing on installing single-use bioprocessing products at their manufacturing facilities. Contract research organizations & manufacturers are installing single-use bioprocessing equipment including bioreactors at a large scale for in-house biomanufacturing. Contract research organizations & manufacturers are using single-use blood bags, transfer sets, T-flasks, and pipettes for cell therapy-based clinical research.
Single-Use Bioprocessing Market Geographical Share
North America region holds the largest market share in the global single-use bioprocessing market
By region, the single-use bioprocessing market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the single-use bioprocessing market due to the higher adoption of single-use bioprocessing systems for the production of vaccines, monoclonal antibiotics, cell therapies, and other therapies. The single-use bioprocessing systems are manufactured by using high-grade polymer materials and plastic composites that provide enhanced integral strength. Several manufacturers are using single-use bioprocessing systems as the use of these systems reduced the overall operational costs and provides continuity in biomanufacturing. There is a presence of large-scale biopharmaceutical manufacturing facilities. The market is witnessing technological advancement including automation, big data, and machine learning (ML) solutions in bioprocessing. These technological advancements are useful for predicting errors and improving accuracy during medical procedures.
Europe single-use bioprocessing market acquired the second position followed by North America in the global market with a prominent share of the market. Significant factors are probable the growth of the market owing to rising R&D initiatives, and huge production capabilities. In the Europe region, the United Kingdom is majorly controlling the market and estimated constant growth over the forecast period. Germany and France are projected to develop prominent growth in the Single-use Bioprocessing Market over the forecast period.
The Asia-Pacific is expected to witness positive market growth over the forecasted period. There is growing usage of single-use bioprocessing systems as these bioprocessing systems have made the drug manufacturing process faster, simpler, and cheaper. The use of single-use bioprocessing systems increases the productivity of the manufacturing of the products. There is a presence of several companies developing single-use bioprocessing systems. Several public and private players are raising their investment in the development of single-use bioprocessing systems.
Single-Use Bioprocessing Companies and Competitive Landscape
The single-use bioprocessing market is highly competitive with the presence of several international and local market players. Product diversification, technological advancement, revenue generation, and opportunities intensify the market competition. 3M Company, Applikon Biotechnology, Cesco Bioengineering Co., Danaher Corporation, General Electric Company, Merck KGaA, PBS Biotech Inc., and Thermo Fisher Scientific Inc. are the leading Market players with significant market share.
Companies are using novel product launches, capacity utilization, technology advancement, new product development, and market expansion strategies for holding their position in the market.
Single-use Bioprocessing Market Key Companies to Watch
Thermo Fisher Scientific Inc.:
Overview: Thermo Fisher is an American company that supplies variety of scientific or analytical instruments, lab reagents & consumables, and some scientific software services. It was founded in 1956 and headquartered in Waltham, Massachusetts, U.S.
Product Portfolio:
Thermo Scientific HyPerforma DynaDrive Single-Use Bioreactor: It is a single-use bioreactor that is better in performance and scalability for larger volumes. It is suitable for perfusion and fed batch processes.
Recent Developments
- March 2026 – Thermo Fisher, Danaher, Merck, and Sartorius dominate global supply chain
Key players including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, and Sartorius are leading innovation in single-use bioreactors, filtration systems, and fluid management platforms. - March 2026 – Cytiva and GE HealthCare strengthen large-scale bioreactor and mixing systems
Cytiva and GE HealthCare are advancing high-volume single-use bioreactors (2,000–5,000 L scale) and magnetic mixing technologies for industrial biologics production. - February 2026 – PBS Biotech and Applikon expand bioreactor innovation for cell therapy scale-up
Companies such as PBS Biotech Inc. and Applikon Biotechnology are focusing on wave bioreactors and perfusion systems optimized for cell and gene therapy manufacturing. - February 2026 – Growing adoption of single-use technologies in CDMO-driven manufacturing
Contract Development and Manufacturing Organizations (CDMOs) are heavily investing in flexible, multi-product single-use facilities to support rapidly expanding biologics pipelines. - January 2026 – Thermo Fisher expands high-capacity single-use systems up to 5,000 L scale
Thermo Fisher Scientific has introduced advanced 5,000 L bioreactor systems with improved oxygen transfer and 27% higher productivity, enabling large-scale biologics manufacturing.
The global single-use bioprocessing market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
